Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae-authors' response

J Antimicrob Chemother. 2023 Mar 2;78(3):854-857. doi: 10.1093/jac/dkad017.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Klebsiella pneumoniae* / drug effects
  • Piperacillin, Tazobactam Drug Combination

Substances

  • Piperacillin, Tazobactam Drug Combination
  • Anti-Bacterial Agents